Literature DB >> 22929522

Analysis of NUP98/NSD1 translocations in adult AML and MDS patients.

F Thol, B Kölking, I H I Hollink, F Damm, M M van den Heuvel-Eibrink, C Michel Zwaan, G Bug, O Ottmann, K Wagner, M Morgan, W K Hofmann, G Göhring, B Schlegelberger, J Krauter, A Ganser, M Heuser.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22929522     DOI: 10.1038/leu.2012.249

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  15 in total

1.  Potent co-operation between the NUP98-NSD1 fusion and the FLT3-ITD mutation in acute myeloid leukemia induction.

Authors:  Angeliki Thanasopoulou; Alexandar Tzankov; Juerg Schwaller
Journal:  Haematologica       Date:  2014-06-20       Impact factor: 9.941

2.  Somatic mutations in murine models of leukemia and lymphoma: Disease specificity and clinical relevance.

Authors:  Liat Goldberg; Sheryl M Gough; Fan Lee; Christine Dang; Robert L Walker; Yuelin J Zhu; Sven Bilke; Marbin Pineda; Masahiro Onozawa; Yang Jo Chung; Paul S Meltzer; Peter D Aplan
Journal:  Genes Chromosomes Cancer       Date:  2017-03-31       Impact factor: 5.006

3.  Low frequency of calreticulin mutations in MDS patients.

Authors:  M Heuser; V Panagiota; C Koenecke; B Fehse; H Alchalby; A Badbaran; R Shahswar; M Stadler; M Eder; G Göhring; A Trummer; T Schroeder; G Kobbe; C Thiede; U Platzbecker; B Schlegelberger; N Kroeger; A Ganser; F Thol
Journal:  Leukemia       Date:  2014-05-21       Impact factor: 11.528

4.  NUP98/NSD1 and FLT3/ITD coexpression is more prevalent in younger AML patients and leads to induction failure: a COG and SWOG report.

Authors:  Fabiana Ostronoff; Megan Othus; Robert B Gerbing; Michael R Loken; Susana C Raimondi; Betsy A Hirsch; Beverly J Lange; Stephen Petersdorf; Jerald Radich; Frederick R Appelbaum; Alan S Gamis; Todd A Alonzo; Soheil Meshinchi
Journal:  Blood       Date:  2014-08-21       Impact factor: 22.113

Review 5.  Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel.

Authors:  Hartmut Döhner; Elihu Estey; David Grimwade; Sergio Amadori; Frederick R Appelbaum; Thomas Büchner; Hervé Dombret; Benjamin L Ebert; Pierre Fenaux; Richard A Larson; Ross L Levine; Francesco Lo-Coco; Tomoki Naoe; Dietger Niederwieser; Gert J Ossenkoppele; Miguel Sanz; Jorge Sierra; Martin S Tallman; Hwei-Fang Tien; Andrew H Wei; Bob Löwenberg; Clara D Bloomfield
Journal:  Blood       Date:  2016-11-28       Impact factor: 22.113

6.  AF10 regulates progressive H3K79 methylation and HOX gene expression in diverse AML subtypes.

Authors:  Aniruddha J Deshpande; Anagha Deshpande; Amit U Sinha; Liying Chen; Jenny Chang; Ali Cihan; Maurizio Fazio; Chun-Wei Chen; Nan Zhu; Richard Koche; Liuda Dzhekieva; Gloria Ibáñez; Stuart Dias; Deepti Banka; Andrei Krivtsov; Minkui Luo; Robert G Roeder; James E Bradner; Kathrin M Bernt; Scott A Armstrong
Journal:  Cancer Cell       Date:  2014-11-20       Impact factor: 31.743

7.  Transcriptional dynamics of homeobox C11 gene in water buffalo bubalus bubalis.

Authors:  Leena Rawal; Deepali Pathak; Neeta Sehgal; Sher Ali
Journal:  DNA Cell Biol       Date:  2015-03-11       Impact factor: 3.311

Review 8.  Histone-modifying enzymes: their role in the pathogenesis of acute leukemia and their therapeutic potential.

Authors:  Ly P Vu; Luisa Luciani; Stephen D Nimer
Journal:  Int J Hematol       Date:  2013-01-04       Impact factor: 2.490

Review 9.  Mechanistic insights and potential therapeutic approaches for NUP98-rearranged hematologic malignancies.

Authors:  Nicole L Michmerhuizen; Jeffery M Klco; Charles G Mullighan
Journal:  Blood       Date:  2020-11-12       Impact factor: 22.113

10.  H3K36 methyltransferase NSD1 regulates chondrocyte differentiation for skeletal development and fracture repair.

Authors:  Rui Shao; Zhong Zhang; Zhan Xu; Huiling Ouyang; Lijun Wang; Hongwei Ouyang; Matthew Greenblatt; Xi Chen; Weiguo Zou
Journal:  Bone Res       Date:  2021-06-07       Impact factor: 13.567

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.